Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer ’s disease: a multicenter study

ConclusionAmyloid PET using18F-florbetapir PET had a substantial clinical impact on AD and non-AD diagnosis and on patient management by enhancing diagnostic confidence. In addition, the quantitative measures may improve the visual interpretation of amyloid positivity.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research